Target Name: LOC107986051
NCBI ID: G107986051
Review Report on LOC107986051 Target / Biomarker Content of Review Report on LOC107986051 Target / Biomarker
LOC107986051
Other Name(s): Uncharacterized LOC107986051 | uncharacterized LOC107986051

LOC107986051: A Potential Drug Target for Neurological Disorders

LOC107986051 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a member of the LOC107986051 family, which is characterized by the presence of a unique transmembrane domain and a distinct N-terminus.

LOC107986051 is involved in a variety of cellular processes, including cell signaling, cell adhesion, and neurotransmission. It has been shown to play a role in the regulation of neural stem cell proliferation and the development of neurodegenerative diseases.

One of the most promising aspects of LOC107986051 is its potential as a drug target. Several studies have suggested that LOC107986051 may be a useful target for the treatment of various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

One of the reasons for the potential of LOC107986051 as a drug target is its unique structure and expression pattern. LOC107986051 is a transmembrane protein that is expressed in a variety of tissues, including the brain, heart, and liver. Its unique N-terminus and transmembrane domain suggest that it may be a difficult target for small molecules, which are often used as drug treatments. However, its expression pattern in various tissues makes it a potential target for antibodies or other biomarkers that can be used to target the protein specifically.

Another potential reason for the interest in LOC107986051 as a drug target is its involvement in several neurological and psychiatric disorders. LOC107986051 has been shown to be involved in the regulation of neural stem cell proliferation, which is a critical process in the development and maintenance of neural tissue. It has also been shown to play a role in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its potential role in neurological and psychiatric disorders, LOC107986051 is also a potential biomarker for these conditions. Several studies have shown that LOC107986051 is downregulated in the brains of individuals with Alzheimer's disease and Parkinson's disease, and that levels of this protein have been associated with the severity of these conditions. This suggests that LOC107986051 may be a useful biomarker for the diagnosis and treatment of Alzheimer's disease and Parkinson's disease.

Overall, LOC107986051 is a protein that has the potential to be a drug target for the treatment of neurological and psychiatric disorders. Its unique structure and expression pattern, as well as its involvement in the regulation of neural stem cell proliferation and the development of neurodegenerative diseases, make it a promising target for small molecules and antibodies. Further research is needed to determine the full extent of LOC107986051's potential as a drug target and to develop effective treatments for the disorders associated with its presence.

Protein Name: Uncharacterized LOC107986051

The "LOC107986051 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107986051 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107986056 | LOC107986092 | LOC107986115 | LOC107986139 | LOC107986141 | LOC107986142 | LOC107986146 | LOC107986148 | LOC107986166 | LOC107986178 | LOC107986186 | LOC107986195 | LOC107986203 | LOC107986205 | LOC107986215 | LOC107986223 | LOC107986229 | LOC107986257 | LOC107986272 | LOC107986286 | LOC107986291 | LOC107986297 | LOC107986298 | LOC107986300 | LOC107986362 | LOC107986368 | LOC107986385 | LOC107986400 | LOC107986420 | LOC107986429 | LOC107986440 | LOC107986451 | LOC107986452 | LOC107986453 | LOC107986454 | LOC107986469 | LOC107986517 | LOC107986522 | LOC107986528 | LOC107986537 | LOC107986544 | LOC107986545 | LOC107986561 | LOC107986589 | LOC107986594 | LOC107986595 | LOC107986597 | LOC107986598 | LOC107986606 | LOC107986613 | LOC107986622 | LOC107986623 | LOC107986626 | LOC107986636 | LOC107986649 | LOC107986666 | LOC107986764 | LOC107986766 | LOC107986770 | LOC107986771 | LOC107986772 | LOC107986774 | LOC107986776 | LOC107986777 | LOC107986781 | LOC107986787 | LOC107986800 | LOC107986816 | LOC107986820 | LOC107986836 | LOC107986844 | LOC107986873 | LOC107986892 | LOC107986894 | LOC107986901 | LOC107986903 | LOC107986927 | LOC107986930 | LOC107986952 | LOC107986961 | LOC107986983 | LOC107986996 | LOC107987026 | LOC107987045 | LOC107987049 | LOC107987053 | LOC107987057 | LOC107987064 | LOC107987087 | LOC107987099 | LOC107987121 | LOC107987164 | LOC107987178 | LOC107987211 | LOC107987243 | LOC107987249 | LOC107987251 | LOC107987282 | LOC107987285 | LOC107987299